Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Malignant Melanoma

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Malignant Melanoma in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research Excerpts

ExcerptRelevanceReference
"Acidosis enhances the antitumor effect of melphalan."7.71Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model. ( Bauer, TW; Buerk, DG; Fraker, DL; Kelley, ST; Menon, C, 2002)
"Acidosis enhances the antitumor effect of melphalan."3.71Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model. ( Bauer, TW; Buerk, DG; Fraker, DL; Kelley, ST; Menon, C, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kelley, ST1
Menon, C1
Buerk, DG1
Bauer, TW1
Fraker, DL1
Zanon, M1
Piris, A1
Bersani, I1
Vegetti, C1
Molla, A1
Scarito, A1
Anichini, A1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Malignant Melanoma

ArticleYear
Acidosis plus melphalan induces nitric oxide-mediated tumor regression in an isolated limb perfusion human melanoma xenograft model.
    Surgery, 2002, Volume: 132, Issue:2

    Topics: Acidosis; Amidines; Animals; Antineoplastic Agents, Alkylating; Apoptosis; Benzylamines; Disease Mod

2002
Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
    Cancer research, 2004, Oct-15, Volume: 64, Issue:20

    Topics: Amidines; Antineoplastic Agents; Apoptosis; Apoptotic Protease-Activating Factor 1; Benzylamines; Ca

2004